Innovation of Technology is the base of enterprise progress. In the past ten more years, BGI-GBI has gained several tens of patents and SFDA certificate. The accomplishment of one project of "Ninth five-year" National Key Technology Research and Development Program, the participation of 1% Human Genome Project, the manufacturing of Anti-Treponema Pallidum (TP) Antibody ELISA Kit and the successful development of SARS detection method have shown the strong R&D abilities of BGI-GBI.
Prospects for future— the blueprint of BGI-GBI
Beijing BGI-GBI Biotech Co., Ltd has made the Research & Technology, Sales & Marketing, Products & Services much more integrated by the past ten more years of efforts. In future years, besides broadening our ELISA product portfolios, BGI-GBI Biotech will be focusing on protein and nucleic acid technologies, integrated with bio-chips to develop the next generation diagnostic products. The company will further evolve its business into technical services to provide total solutions to enterprise customers. As a renowned leader in the diagnostic industry with more than ten years of experience, abundant supply of qualified personnel and other resources and an extensive network over the country, BGI-GBI Biotech would like to co-operate with you in all areas, from product development, OEM activities, to mutual product promotion and distribution.